Powders are a big part of everyday life, from baking and laundry to cosmetics and pharmaceuticals. Understanding powder rheology—how powders flow and deform—is crucial for optimizing their use in various applications. This knowledge helps industries maintain consistency and product quality.
When it comes to selecting materials for your next innovative product, the material specification sheet is likely the first place that you will turn. This document provides core properties measured by the manufacturer and serves as an essential tool for supplier verification and new product development. However, while these sheets are reliable and provide a standard method for comparison, they often fail to tell the whole story.
Our world is brimming with viscoelastic materials: The dough you knead before baking a fresh loaf, the Silly Putty your toddler slaps against the wall, the rubber gaskets that create an airtight seal on an airplane door. Testing those materials by applying controlled deformations (strains) or forces (stresses) at various timescales, temperatures, and/or humidities allows for the optimization of properties and ensures durability and safety.
Biologic therapies derived from living organisms have revolutionized the treatment of complex diseases, yet their high development costs are often passed onto patients. Biosimilar drugs offer a promising solution to reduce costs while maintaining therapeutic efficacy. Unlike generic drugs, biosimilars cannot be exact replicas of their reference biologics due to their complex structures, necessitating rigorous testing and regulatory approval.
The composites market is evolving fast. Global market projections indicate a 10.8 % growth by 2028, driven by the demand for composites across industries looking for materials with superior performance at reduced weight and cost.1 This blog explores how advanced material analysis can enhance R&D and manufacturing processes in the composites market, ultimately leading to financial savings and increased efficiency.
The stability of high-concentration drugs can change under storage conditions, but until now, thermal testing in the lab using traditional calorimetry methods has been time-consuming and challenging. The new TA Instruments RS-DSC fills a critical antibody formulation development gap by allowing for high-throughput short-term thermal stability testing at formulation strength concentrations. In this blog, we explore why that’s essential.
从医疗设备的塑料到轮胎的橡胶，我们使用的材料必须满足越来越高的要求。产品制造商和消费者希望他们的材料外观漂亮，性能好，成本低，同时对环境友好。如需满足上述需求，就必须深入了解从分子水平到实际机械性能的材料特性。由于影响材料特性的因素有很多，因此需要精确的测量工具和方法来确保材料满足应用的高期望值。在开发和生产的各个阶段，评估材料特性的一个关键测量和分析方法是动态机械分析（DMA）。
Will my paint coat the wall or drip off? Will my topical pharmaceutical spread on skin or form clumps? Rheology answers vital questions to inform how we create and interact with materials on a daily basis.
High-performance polymers are a critical material for manufacturers due to their combination of mechanical, thermal, and chemical properties, but especially their cost. Without adequate testing, manufacturers could run into a slew of issues, from immediate product failure to poor performance or failure after some time in usage.
The method of drug delivery significantly influences the final stages of the manufacturing process. Currently, lyophilization—a widely adopted technique—enables drug developers to stabilize formulations and therapeutic molecules using a validated commercial approach. In this process, precise control of pressure and temperature within a lyophilizer facilitates the removal of liquids from formulations containing thermally sensitive or hydrolytically unstable active pharmaceutical ingredients or formulation components.
Against the backdrop of a plastic waste crisis, the global demand for plastic is set to quadruple by 2060. This has driven a shift toward sustainability and away from linear use models of plastic production. Post-consumer resin (PCR) has emerged as a key player in circular economy initiatives, though ensuring the quality and performance of PCR requires several characterization considerations.
As a central pillar of modern society, the pharmaceutical industry bears the load of billions of lives around the world. In 2022, the global revenue of the pharmaceutical industry approximated $1.5 trillion, a figure reflected in two decades of significant growth.